Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioha Laboratories is a medical aesthetics and healthcare products company focused on hyaluronic acid-based fillers and related aesthetic consumables. The company states it was established in 2003 and is an early Chinese producer of medical sodium hyaluronate gel. Its core commercial brand appears to be Reyoungel, a line of cross-linked hyaluronic acid dermal fillers sold internationally, alongside mesotherapy solutions, cannulas, needles, PDO threads, and related beauty products. Bioha operates as a manufacturing and export-oriented business rather than a therapeutic drug developer, with commercial distribution in more than 30 countries. Available evidence indicates the company is active and privately held, with operating entities in China and Hong Kong and a UK group presence used for international business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioha.